Brooklyn Immunotherapeutics Inc (NASDAQ:BTX)

5.50
Delayed Data
As of 4:00pm ET
 -0.45 / -7.56%
Today’s Change
3.59
Today|||52-Week Range
80.67
+22.77%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Brooklyn Immunotherapeutics Inc have a median target of 20.00, with a high estimate of 20.00 and a low estimate of 20.00. The median estimate represents a +263.64% increase from the last price of 5.50.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Brooklyn Immunotherapeutics Inc. This rating has held steady since October, when it was upgraded from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.09
Sales
--
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 94.71%
 
 
 
 
 
Growthannually 37.50%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
Growthannually 468.61%
 
 
 
 
 
Key to the earnings and sales forecast charts.